je.st
news
Leading Hematology Journal Publishes Pivotal ELOCTATE Data that...
2013-11-14 00:31:08| Appliances - Topix.net
WESTON, Mass. & STOCKHOLM-- -- Today Biogen Idec and Swedish Orphan Biovitrum AB announced that the detailed phase 3 data for the companies' investigational long-lasting recombinant factor VIII Fc fusion protein candidate ELOCTATEa were published online in Blood , the journal of the American Society of Hematology .
Tags: data
journal
leading
publishes
Category:Consumer Goods and Services
Latest from this category |
All news |
||||||||||||||||||
|